Logo

SAI PARENTERALS LIMITED Share Price

NSE: SAIPARENT
|
Pharmaceuticals
₹ 618.60
-₹5.20 (-0.83%)
1D
Last updated 03 Jul, 2026, 15:56 IST

₹613.70
0.83% down today
₹633.15
1D LOW
1D HIGH

SAI PARENTERALS LIMITED Returns Calculator

Open
₹625.00
High
₹633.15
Low
₹613.70
Prev. close
₹623.80

Circuit
L
H
₹494.90
₹742.30
52-week
L
H
₹400.00
₹706.00

SAI PARENTERALS LIMITED Shareholder Returns

SAI PARENTERALS LIMITED Share Price History

Mkt Cap Cr
0.00

P/E

P/B
5.90

ROE
3.45%

D/E
0.27

ROCE
4.43%

Div. Yield
0.00%

EPS(TTM)
5.13
Turnover
0.31

EV/EBITDA

Net Margin
0.00%

Op. Margin
0.00%

ROA

Quick Ratio
0.00

Curr. Ratio
3.23
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sai Parenteral's outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Sai Parenteral's appears to be fairly valued compared to its peers
Step 4 of 5
Earnings
Good
Sai Parenteral's revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

SAI PARENTERALS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹163.11₹153.76₹96.80
Other Income₹0.64₹1.42₹0.23
Total Revenue₹163.74₹155.18₹97.03
Total Expenses₹143.84₹142.63₹89.78
Profit Before Tax₹19.91₹12.56₹7.25
Tax₹5.48₹4.14₹2.87
Profit After Tax₹14.43₹8.42₹4.38
EPS - Basic₹5.43₹10.54₹6.16
EPS - Diluted₹5.43₹10.54₹6.16

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹19.91₹12.56₹7.25
Income before WC changes₹40.34₹33.25₹18.82
Change in Assets-₹14.87-₹101.20-₹39.64
Change in Liabilities₹8.23₹38.12₹10.71
Change in WC-₹6.64-₹63.08-₹28.92
Cash flow from Operations₹33.15-₹29.76-₹12.80
Cash flow from Investing₹0.44-₹46.32-₹19.03
Cash flow from Financing-₹35.88₹78.57₹23.98
Total Cash Flow-₹2.30₹2.48-₹7.85
Cash (Start of the year)₹4.38₹1.90₹9.75
Cash (End of the year)₹2.09₹4.38₹1.91

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹72.47₹80.75₹52.02
Current Assets₹199.92₹187.35₹81.94
Total Assets₹272.39₹268.10₹133.96
Current Liabilities₹162.35₹152.79₹76.63
Net Current Asset₹37.57₹34.56₹5.31
Non-Current Liabilities₹14.25₹38.91₹25.84
Equity Capital₹95.78₹76.40₹31.49
Total Equity & Liabilities₹272.39₹268.10₹133.96

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹124.27₹113.89₹96.80
Other Income₹0.24₹1.09₹0.19
Total Revenue₹124.51₹114.97₹96.98
Total Expenses₹110.10₹104.74₹89.75
Profit Before Tax₹14.39₹10.20₹7.25
Tax₹4.05₹3.04₹2.67
Profit After Tax₹10.34₹7.16₹4.58
EPS - Basic₹3.89₹8.95₹6.46
EPS - Diluted₹3.89₹8.95₹6.46

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹14.39₹10.20₹7.25
Income before WC changes₹27.06₹22.49₹18.70
Change in Assets-₹22.38-₹34.71-₹40.42
Change in Liabilities₹9.17₹11.01₹3.59
Change in WC-₹13.21-₹23.71-₹36.83
Cash flow from Operations₹9.80-₹4.43-₹20.83
Cash flow from Investing-₹4.27-₹31.97-₹17.26
Cash flow from Financing-₹5.81₹35.88₹30.23
Total Cash Flow-₹0.29-₹0.52-₹7.85
Cash (Start of the year)₹1.38₹1.91₹9.76
Cash (End of the year)₹1.10₹1.38₹1.91

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹82.74₹73.56₹48.25
Current Assets₹132.41₹120.48₹85.72
Total Assets₹215.15₹194.04₹133.97
Current Liabilities₹111.32₹97.27₹76.63
Net Current Asset₹21.09₹23.21₹9.09
Non-Current Liabilities₹12.49₹18.69₹25.86
Equity Capital₹91.34₹78.08₹31.48
Total Equity & Liabilities₹215.15₹194.04₹133.97
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
618.6
2046
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2046
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
74.76
Bullish

ATR (14)
27.07
Neutral

STOCH(9,6)
33.56
Neutral

STOCH RSI (14)
53.41
Neutral

ADX(9)
71.25
Bearish

UO(9)
33.9
Neutral

ROC(12)
8.1
Bullish

WillR(14)
-61.55
Neutral
Period
Simple value
Exponential vaue

5D
606.06
609.68

10D
598.64
598.74

20D
581.12
579.12

50D
525.73
581.41

100D
508.98
0

About SAI PARENTERALS LIMITED

SAI PARENTERALS LIMITED logo
ISIN
INE0H9F01037
Sector Market Cap

SAI PARENTERALS LIMITED Financial Highlights

  • Revenue: SAI PARENTERALS LIMITED reported revenue of ₹389.52 crore in FY26 vs ₹163.75 crore in FY25. It showed an increase of 137.87% on a yearly basis.
  • Operating Profit: SAI PARENTERALS LIMITED reported an operating profit of ₹11.93 crore in FY26 vs ₹19.91 crore in FY25. It showed a decrease of 40.08% on a year-on-year basis.
  • Net Profit: SAI PARENTERALS LIMITED reported a net profit of ₹14.26 crore in FY26 vs ₹14.43 crore in FY25. It showed a decrease of 1.18% on a yearly basis.

SAI PARENTERALS LIMITED Quarterly Result Highlights

  • SAI PARENTERALS LIMITED reported revenue of ₹200.81 crore in Mar 2026, compared with ₹99.28 crore in Dec 2025, representing an increase of 102.27% on a quarter-on-quarter (QoQ) basis.
  • SAI PARENTERALS LIMITED reported an operating profit of ₹12.39 crore in Mar 2026, compared with ₹11.62 crore in Dec 2025, representing an increase of 206.63% on a quarter-on-quarter (QoQ) basis.
  • SAI PARENTERALS LIMITED reported a profit of ₹13.16 crore in Mar 2026, compared with ₹6.66 crore in Dec 2025, reflecting an increase of 297.60% on a QoQ basis.
  • The earnings per share (EPS) of SAI PARENTERALS LIMITED stood at ₹5.43 during Mar 2026.
Know more
Promoters
51.16%
FII
5.73%
Other DII
9.05%
Retail and other
30.26%
Mutual funds
3.81%
Foreign institutions - FII
Compare against other stocks
SAI PARENTERALS LIMITED logo
SAI PARENTERALS LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on SAI PARENTERALS LIMITED Share Price